Search clinical trials for: Alpha1-Proteinase Inhibitor

Total 68962 results

Nanfang Hospital of Southern Medical University
Guangdong No.2 Provincial People's Hospital; Foshan Hospital of Traditional... and other collaborators

Enrolling by invitation

Effect of Early Treatment With Sivelestat Sodium in ARDS Patients (siv-ARDS)

Inflammatory Response | ARDS

China
Children's Hospital Los Angeles
Baylor College of Medicine; Children's Hospital of Philadelphia; Children's Hospital... and other collaborators

Completed

The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids (UNBLOCK)

Deep Venous Thrombosis

United States
Maastricht University

Not yet recruiting

In Vivo Effects of Amylase Trypsin Inhibitors (ATI)

Irritable Bowel Syndrome | Non-Coeliac Wheat Sensitivity (NCWS)
Heidelberg Pharma AG

Completed

Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer

Spain, Germany, Hungary, Italy, Russian Federation, Ukraine
Lin Zhao

Recruiting

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

In-stent Restenosis | Major Adverse Cardiovascular Events

China
Seoul National University Hospital
Medtronic Korea Co., Ltd.; Samjin Pharmaceutical Co., Ltd.

Recruiting

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation (POCKET-OAC)

Atrial Fibrillation

Korea, Republic of
J.P.S Henriques

Not yet recruiting

Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention (IMPACT AF-PCI)

Coronary Artery Disease | Atrial Fibrillation
China National Center for Cardiovascular Diseases
Chinese Academy of Medical Sciences, Fuwai Hospital

Recruiting

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

Non-Valvular Atrial Fibrillation

China
Shanghai Zhongshan Hospital

Recruiting

Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis

Venous Thrombosis

China
University Hospital, Ghent

Recruiting

The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden

Covid19

Belgium
Second Affiliated Hospital, School of Medicine,...
Bayer; The Central Hospital of Lishui City; Shaoxing People's Hospital; Wenzhou... and other collaborators

Recruiting

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

Intracranial Hemorrhages | Anticoagulant | Cerebrovascular Stroke | Matrix Metalloproteinases

China
Portola Pharmaceuticals
Merck Sharp & Dohme LLC

Completed

A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Renal Impairment

Germany
Daiichi Sankyo, Inc.
Daiichi Sankyo Deutschland GmbH

Completed

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ENCOURAGE-AF)

Non-valvular Atrial Fibrillation

Germany
Daiichi Sankyo Turkey, a Daiichi Sankyo Company
Daiichi Sankyo, Inc.

Completed

Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)

Atrial Fibrillation

Turkey
Daiichi Sankyo, Inc.
Quintiles, Inc.

Completed

Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes

Atrial Fibrillation

Denmark, Hungary, Croatia, Serbia, Spain, Russian Federation, Bulgaria, Latvia, Czechia, Poland, Estonia, Belgium, Lithuania, Slovakia, Ukraine
Bristol-Myers Squibb

Completed

Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis

End Stage Renal Disease

United States
Imperial College London
British Heart Foundation

Completed

Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass

Angina Pectoris | Ischemic Heart Disease

United Kingdom
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients (Thrombosis)

Cancer | Catheter Complications | Thrombosis, Venous

China
Daiichi Sankyo
Daiichi Sankyo Korea Co., Ltd.

Recruiting

A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation (SILVERCARE_AF)

Atrial Fibrillation

Korea, Republic of
University Hospital, Tours

Not yet recruiting

Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients (CARD-AXA)

Chronic Hemodialysis Patients
Mayo Clinic
Ottawa Heart Institute Research Corporation

Recruiting

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

Radial Artery Occlusion

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Apixaban

Obesity, Morbid

Norway
Bayer

Completed

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Atrial Fibrillation | Prevention of Thromboembolic Events

United States
Daiichi Sankyo, Inc.
Daiichi Sankyo (China) Holdings Co., Ltd.

Active, not recruiting

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China (ETNA-AF-CHINA)

Non-valvular Atrial Fibrillation

China
LiuZhou People's Hospital

Unknown

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

Cancer | Rivaroxaban | Thromboprophylaxis
Peking Union Medical College Hospital
Xiangya Hospital of Central South University; Ruijin Hospital; China-Japan Friendship...

Recruiting

The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

Pulmonary Embolism

China
University of Vermont Medical Center
Dartmouth-Hitchcock Medical Center; MaineHealth

Not yet recruiting

Venous Thromboembolism Prevention in Outpatients With Glioma (VTE-POG)

Glioblastoma | Astrocytoma | Venous Thromboembolism
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Recruiting

Pharmacokinetics of Apixaban in Peritoneal Dialysis

Atrial Fibrillation

Hong Kong
Seoul National University Hospital

Not yet recruiting

Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation

Fontan Operation | Protein-Losing Enteropathy | Camostat Mesylate
China National Center for Cardiovascular Diseases

Recruiting

An Exploratory stuDy of effectIveneSs and Safety of rivarOxaban in Patients With Left VEntricular Thrombus (R-DISSOLVE) (R-DISSOLVE)

Ventricular Mural Thrombosis

China
General Hospital of Shenyang Military Region

Recruiting

Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation (ERSAF)

Cerebral Infarction | TIA

China
Seoul National University Hospital

Active, not recruiting

Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient

Atrial Fibrillation

Korea, Republic of
Stanford University

Completed

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol

Covid19

United States
Stanford University

Terminated

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol (COPPS)

Covid19

United States
Assistance Publique - Hôpitaux de Paris

Terminated

CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients (CAMOVID)

Covid19

France
University Hospital Inselspital, Berne

Terminated

Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve. (CATHAR)

Aortic Valve Disease | Anticoagulants | Heart Valve Prosthesis Implantation

Switzerland
Bristol-Myers Squibb

Completed

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Anticoagulation

France
Janssen Scientific Affairs, LLC
Bayer

Completed

Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants

Pharmacokinetics | Healthy Participants | Bioavailability

United States
Yonsei University

Completed

Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy

Renal Mass

Korea, Republic of
Pfizer

Completed

Food Effect Study For Apixaban Commercial Image Tablets

Healthy

Singapore
Texas Biotechnology Corporation

Completed

Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis

Kidney Failure, Chronic | Renal Disease, End-Stage

United States
Nanjing Medical University
Beijing Anzhen Hospital

Not yet recruiting

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Sivelestat) VI

Systemic Inflammatory Response Syndrome | Aortic Dissection

China
Brigham and Women's Hospital

Completed

Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

Atrial Fibrillation

United States
University of Alberta
Boehringer Ingelheim

Completed

Canadian Pradaxa Acute Stroke Safety Study (CPASS)

Stroke | Ischemic Attack, Transient

Canada
Lawson Health Research Institute
Boehringer Ingelheim

Completed

DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation (DAPPARAF)

Atrial Fibrillation

Canada
Nycomed

Completed

ImproveR International (BI-001-IM)

Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)

Denmark
Southeast University, China

Recruiting

Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis

ARDS

China
Octapharma

Recruiting

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Congenital Antithrombin Deficiency

Spain, Italy, United States, Serbia, France, Hungary, Austria, Germany, United Kingdom, Israel
Brigham and Women's Hospital

Completed

Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Ural State Medical University
Boehringer Ingelheim

Unknown

Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study) (RE-SOUND)

Atrial Fibrillation

Russian Federation

Search clinical trials for: Alpha1-Proteinase Inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations